Response: Re: Effects of Implementing a Comprehensive Opioid Reduction Protocol on Overall Opioid Prescribing Among Patients with Chronic, Non-Cancer Pain in a Rural Family Medicine Clinic: A Controlled Crossover Trial

被引：0
|
作者：
不详
机构：
来源：
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE | 2021年 / 34卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：243 / 243
页数：1
相关论文
共 9 条
  • [1] Effects of Implementing a Comprehensive Opioid Reduction Protocol on Overall Opioid Prescribing Among Patients with Chronic, Non-Cancer Pain in a Rural Family Medicine Clinic: A Controlled Cross-over Trial
    Stack, Matthew
    LaRouche, Vanessa
    Zhang, Yezi
    Warden, Daniel
    Stack, Charles
    Klugiene, Egle A.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2020, 33 (04) : 502 - 511
  • [2] Effects of state opioid prescribing cap laws on providers' opioid prescribing patterns among patients with chronic non-cancer pain
    Tormohlen, Kayla N.
    White, Sarah A.
    Bandara, Sachini
    Bicket, Mark C.
    McCourt, Alexander D.
    Davis, Corey S.
    McGinty, Emma E.
    PREVENTIVE MEDICINE, 2023, 172
  • [3] Randomised, pragmatic, waitlist controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: study protocol
    Jashinski, Julia
    Grossman, Ellie
    Quaye, Aurora
    Cather, Corinne
    Potter, Kevin
    Schoenfeld, David A.
    Evins, A. Eden
    Gilman, Jodi M.
    BMJ OPEN, 2022, 12 (06):
  • [4] A COMPREHENSIVE CLINIC-BASED STRATEGY TO PROMOTE SAFE OPIOID PRESCRIBING FOR CHRONIC NON-CANCER PAIN IN THE PRIMARY CARE SETTING
    James, Jocelyn
    Klein, Jared W.
    Chew, Lisa
    Merrill, Joseph
    Jackson, Sara L.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2014, 29 : S472 - S472
  • [5] Feasibility study of a Behavioural Intervention for Opioid Reduction (BIOR) for patients with chronic non-cancer pain in primary care: a protocol
    Poole, Helen M.
    Frank, Bernhard
    Begley, Emma
    Woods, Aimee
    Ramos-Silva, Andreia
    Merriman, Mike
    McCulough, Roisin
    Montgomery, Catharine
    BMJ OPEN, 2023, 13 (01):
  • [6] Opioid Medication Use Among Chronic Non-Cancer Pain Patients Assessed with a Modified Drug Effects Questionnaire and the Association with Opioid Use Disorder
    Boscarino, Joseph A.
    Withey, Carrie A.
    Dugan, Ryan J.
    Hu, Yirui
    Auciello, Jessica
    Alfieri, Thomas
    JOURNAL OF PAIN RESEARCH, 2020, 13 : 2697 - 2705
  • [7] Experiencing the risk of overutilising opioids among patients with chronic non-cancer pain in ambulatory care (ERONA): the protocol of an exploratory, randomised controlled trial
    Wegwarth, Odette
    Spies, Claudia
    Schulte, Erika
    Meerpohl, Joerg J.
    Schmucker, Christine
    Nury, Edris
    Brockmann, Dirk
    Donner-Banzhoff, Norbert
    Wind, Stefan
    Goebel, Eva
    Ludwig, Wolf-Dieter
    Hertwig, Ralph
    BMJ OPEN, 2020, 10 (09):
  • [8] A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Lubiprostone for the Treatment of Opioid-Induced Bowel Dysfunction in Patients With Chronic, Non-Cancer Pain
    Cryer, Byron L.
    Katz, Seymour
    Vallejo, Ricardo
    Scott, Charles B.
    Joswick, Taryn R.
    Dolecek, Gayle
    Ueno, Ryuji
    GASTROENTEROLOGY, 2010, 138 (05) : S129 - S129
  • [9] Lubiprostone Significantly Improves Treatment Response in Non-Methadone Opioid-Induced Bowel Dysfunction Patients with Chronic, Non-Cancer Pain: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Jamal, M. Mazen
    Mareya, Shadreck M.
    Woldegeorgis, Fasil
    Joswick, Taryn R.
    Joswick, Ryuji Ueno
    GASTROENTEROLOGY, 2012, 142 (05) : S144 - S145
1